Capricor Therapeutics News, Capricor Therapeutics Quote, CAPR Quote

Capricor Therapeutics (NQ:CAPR) Delayed: 10.03 +0.02 (0.20%)

Prev. Close

$10.01

Today 6M 1Y 5Y

Open

$10.07

52 Wk High

$5.40

52 Wk Low

$1.88

Day High

$10.65

Day Low

$9.89

P/E

N/A

EPS

$0.00

Volume

1,931,824

Friends, Peers and Foes (?): ARWR, ALNY, ARVN, CRSP, CTMX (more...)

ALERTS | RSS

Sep 1, 2026 09:07 AM Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
Sep 1, 2026 03:47 AM Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date'
Aug 31, 2026 01:11 PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 28, 2026 05:49 PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 26, 2026 09:39 PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 25, 2026 06:57 AM Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
Aug 24, 2026 12:18 PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 24, 2026 10:54 AM Increasing unusual put volume: CAPR EYPT WPM ROST CBRG LNC FVRR IOT IOVA PR BNTX TEVA HWM MRNA BLSH BMNU
Aug 24, 2026 10:20 AM FDA extends Capricor deramiocel review to November 22, HC Wainwright comments
Aug 24, 2026 09:25 AM Form 8-K CAPRICOR THERAPEUTICS, For: Aug 24

Entities mentioned with CAPR

View All Entities